Medindia LOGIN REGISTER
Medindia
Novel Genomic Areas Linked to Stroke can Lead to Targeted Treatments

Novel Genomic Areas Linked to Stroke can Lead to Targeted Treatments

by Dr. Trupti Shirole on Oct 6 2022 11:00 AM
Listen to this article
0:00/0:00

Highlights:
  • Stroke is the second biggest cause of mortality globally, accounting for 12% of all fatalities. (Its prevalence is rising, especially in low-income nations) this can be another point – Prevalence of stroke is rising especially in low-income nations
  • People from India and Pakistan who experience neurological issues have higher COBL frequency in their genomes. This can lead to the development of targeted therapies for stroke
Stroke is the second-leading cause of mortality in the world. It has been linked to 61 novel genomic areas that could be targeted for drugs.
Previous genome-based research on stroke was primarily done in populations of European ancestry. The most current findings, which were just published in the journal Nature, were derived from the data analysis of 2.5 million individuals from five distinct ancestries, over 200,000 of whom had experienced a stroke.


Advertisement

Stroke Prevalence in Different Countries

“The population studied in this research has a fairly global representation including South Asia, which includes India and Pakistan, Africa, East Asia, Europe and Latin America,” said Prasad, the director of Rajendra Institute of Medical Sciences, Ranchi. “The combined results from different ancestries and regions made things clearer at a micro level,” he added.

The team found association signals for stroke and its subtypes at 89 (61 new) distinct gene loci in 110,182 stroke patients and 1,503,898 control persons. Loci, often known as genetic street addresses, are the actual places where genes are located on chromosomes in living cells.

87% of the primary stroke risk regions and 60% of the secondary stroke risk regions were replicated during a follow-up in 89,084 additional stroke cases and 1,013,843 control people.


Advertisement

Potential Drug Targets for Treatment of Stroke

The study also identified additional potential targets, including the F11, KLKB1, PROC, GP1BA, LAMC2, and VCAM1 regions. Drugs are already being developed for the treatment of stroke in the F11 and PROC regions.

Data from 4,088 people, including 1,609 stroke cases and 2,479 controls, from South Asia, which includes Pakistan and India, were given by Prasad and his team. They discovered that individuals from India and Pakistan who suffer from neurological problems have greater frequencies of a genomic region known as COBL. Patients of other ancestries did not have a higher frequency of this location.

“Our results provide insights to inform biology, reveal potential drug targets and derive genetic risk prediction tools across ancestries,” Prasad noted.


Advertisement

What is Stroke

Stroke is characterized by an abrupt neurological deficit onset. It is frequently brought on by cerebral ischemia, a common mechanism of acute brain injury brought on by reduced blood supply to the brain. The prevalence of small-vessel stroke (SVS) and intracerebral hemorrhage (ICH) is higher in Asian and African people than in European ones, demonstrating that the frequency of stroke subtypes varies by ancestral group.

Source-Medindia


Advertisement